Premium
Impact of hormonal contraception and weight loss on high‐density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome
Author(s) -
Dokras Anuja,
Playford Martin,
KrisEtherton Penny M.,
Kunselman Allen R.,
Stetter Christy M.,
Williams Nancy I.,
Gnatuk Carol L.,
Estes Stephanie J.,
Sarwer David B.,
Allison Kelly C.,
Coutifaris Christos,
Mehta Nehal,
Legro Richard S.
Publication year - 2017
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.13310
Subject(s) - medicine , endocrinology , polycystic ovary , cholesterol , lipoprotein , oral contraceptive pill , overweight , high density lipoprotein , body mass index , insulin resistance , population , obesity , family planning , environmental health , research methodology
Summary Objective To study the effects of oral contraceptive pills ( OCP ), the first‐line treatment for PCOS , on high‐density lipoprotein cholesterol ( HDL ‐C) function (reverse cholesterol efflux capacity) and lipoprotein particles measured using nuclear magnetic resonance spectroscopy in obese women. Design Secondary analysis of a randomized controlled trial ( OWL ‐ PCOS ) of OCP or Lifestyle (intensive Lifestyle modification) or Combined ( OCP + Lifestyle) treatment groups for 16 weeks. Patients Eighty‐seven overweight/obese women with PCOS at two academic centres. Measurements Change in HDL ‐C efflux capacity and lipoprotein particles. Results High‐density lipoprotein cholesterol efflux capacity increased significantly at 16 weeks in the OCP group [0·11; 95% confidence interval ( CI ) 0·03, 0·18, P = 0·008] but not in the Lifestyle ( P = 0·39) or Combined group ( P = 0·18). After adjusting for HDL ‐C and TG levels, there was significant mean change in efflux in the Combined group (0·09; 95% CI 0·01, 0·15; P = 0·01). Change in HDL ‐C efflux correlated inversely with change in serum testosterone ( r s = −0·21; P = 0·05). In contrast, OCP use induced an atherogenic low‐density lipoprotein cholesterol ( LDL ‐C) profile with increase in small ( P = 0·006) and large LDL ‐particles ( P = 0·002). Change in small LDL ‐particles correlated with change in serum testosterone ( r s = −0·31, P = 0·009) and insulin sensitivity index ( ISI ; r s = −0·31, P = 0·02). Both Lifestyle and Combined groups did not show significant changes in the atherogenic LDL particles. Conclusions Oral contraceptive pills use is associated with improved HDL ‐C function and a concomitant atherogenic LDL ‐C profile. Combination of a Lifestyle program with OCP use improved HDL ‐C function and mitigated adverse effects of OCP on lipoproteins. Our study provides evidence for use of OCP in overweight/obese women with PCOS when combined with Lifestyle changes.